Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Firebrick Pharma Limited ( (AU:FRE) ) is now available.
Firebrick Pharma Limited has announced the quotation of 11,578,947 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of March 5, 2025. This move is part of a previously announced transaction and is expected to enhance the company’s market presence and liquidity, potentially benefiting stakeholders by increasing the company’s visibility and access to capital.
More about Firebrick Pharma Limited
Firebrick Pharma Limited operates in the pharmaceutical industry, focusing on the development and commercialization of health-related products.
YTD Price Performance: 50.0%
Average Trading Volume: 156,775
Technical Sentiment Consensus Rating: Sell
For detailed information about FRE stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money